Disclosure of interest: Nothing to Disclose Scientific Communications: prognosis & outcomes 03.00 - RECOVERY, REHABILITATION AND OUTCOME - 03.03 - PROGNOSIS AND OUTCOME AFTER STROKE O - ESOC25-76 LONGITUDINAL BRAIN AGEING AFTER STROKE: A MARKER FOR SECONDARY POST-STROKE DEGENERATION AND ITS RELEVANCE FOR MOTOR OUTCOME Raphael Takyi 1 , Jeanette Plantin 2 , Sylvain Charron 1 , Marc Maier 3 , Jean-Claude Baron 4 , Guillaume Turc 5 , Rosso Charlotte 6 , Clment Debacker 1 , Pavel Lindberg 1 1 Institute of Psychiatry and Neuroscience of Paris, Paris, France, 2 Karolinska Institute, Stockholm, Sweden, 3 Universit Paris Cit, INCC UMR 8002, CNRS, Paris, France, 4 Institute of Psychiatry and Neuroscience of Paris, GHU-Paris Psychiatrie et Neurosciences - Neurology, Paris, France, 5 GHU-Paris Psychiatrie et Neuroscience - Neurology, Institute of Psychiatry and Neuroscience of Paris, Paris, France, 6 Sorbonne Universit, Inserm U 1127, APHP Urgences CrebroVasculaires, Hpital Piti- Salptrire, CNRS UMR 7225, STARE team, iCRIN, Inst
Logan, M.D
Unreconstituted lyophilised stock freezes well for 12 years
Research Benefits Potential for Synergistic Effects Researchers aim to investigate whether the combination of CJC-1295 No Dac and Ipamorelin may exhibit synergistic effects, enhancing growth hormone-related outcomes
Researchers interested in peptide purity testing , HPLC peptide analysis , LC-MS verification , capsule formulation standards, laboratory handling, storage recommendations, analytical testing, and research peptide quality control can visit our Research Peptide Guides
As a BPC-157 wholesale vendor in Canada , our focus is on helping customers secure reliable sourcing solutions while maintaining efficient procurement processes
.png)
